Add to ORKGThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of single combined (long‐ or short‐acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma
The article is devoted to the concept of early treatment of patients with intermittent and slight co...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
Abstract Background Current guidelines recommend a single inhaler maintenance and reliever therapy (...
Background In people with mild asthma poor adherence to regular therapy is common and increases the ...
Background: In people with mild asthma poor adherence to regular therapy is common and increases the...
Background Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treat...
Background Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treat...
Recognising that mild asthmatics are at risk of exacerbations and mortality, the Global Initiative f...
The National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of ...
Asthma is a common condition characterised by inflammation, airway hyperresponsiveness and reversibl...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
: Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formote...
Background: Adding a long-acting ?2-agonist (LABA) to inhaled corticosteroids (ICS) using a fixed-do...
Introduction In adults with mild-moderate asthma, poor adherence to daily maintenance inhaled corti...
Recent clinical trials of as-needed fixed-dose combination of ICS/formoterol have provided new evide...
The article is devoted to the concept of early treatment of patients with intermittent and slight co...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
Abstract Background Current guidelines recommend a single inhaler maintenance and reliever therapy (...
Background In people with mild asthma poor adherence to regular therapy is common and increases the ...
Background: In people with mild asthma poor adherence to regular therapy is common and increases the...
Background Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treat...
Background Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treat...
Recognising that mild asthmatics are at risk of exacerbations and mortality, the Global Initiative f...
The National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of ...
Asthma is a common condition characterised by inflammation, airway hyperresponsiveness and reversibl...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
: Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formote...
Background: Adding a long-acting ?2-agonist (LABA) to inhaled corticosteroids (ICS) using a fixed-do...
Introduction In adults with mild-moderate asthma, poor adherence to daily maintenance inhaled corti...
Recent clinical trials of as-needed fixed-dose combination of ICS/formoterol have provided new evide...
The article is devoted to the concept of early treatment of patients with intermittent and slight co...
In both children and adults with persistent asthma, treatment with an inhaled corticosteroid (ICS) i...
Abstract Background Current guidelines recommend a single inhaler maintenance and reliever therapy (...